Inventor
THOMPSON DAVID D
US49 patents
⚠️ This page may combine multiple inventors who share the name “THOMPSON DAVID D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
40 patentsUS6512002B2Jan 28, 2003
Methods of treatment for premature ejaculation in a male
PFIZER141 citations97
US7030157B2Apr 18, 2006
Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
PFIZER66 citations96
US6107331AAug 22, 2000
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER50 citations96
US5889042AMar 30, 1999
Method of treating diseases and conditions with estrogen agonists and antagonists
PFIZER54 citations96
US5441986AAug 15, 1995
Estrogen agonists as remedies for prostate and cardiovascular diseases
PFIZER48 citations96
US6756401B2Jun 29, 2004
Compositions and methods for treating osteoporosis and lowering cholesterol
PFIZER51 citations94
US5827892AOct 27, 1998
Use of droloxifene for the treatment of cardiovascular diseases
PFIZER32 citations94
US6610719B2Aug 26, 2003
Use of prostaglandin (PGE2) receptor a (EP4) selective agonists for the treatment of acute and chronic renal failure
PFIZER56 citations93
US6436977B1Aug 20, 2002
Dosing regimens for lasofoxifene
PFIZER22 citations93
US5852059ADec 22, 1998
Use of droloxifene for the treatment of protastic disease, endometriosis and obesity
PFIZER28 citations93
US6911456B2Jun 28, 2005
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER12 citations92
US6649657B2Nov 18, 2003
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER16 citations92
US6613796B2Sep 2, 2003
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER13 citations92
US6355670B1Mar 12, 2002
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER17 citations92
US6323232B1Nov 27, 2001
Combination therapy for osteoporosis
PFIZER17 citations92
US6288120B1Sep 11, 2001
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER30 citations92
US6017964AJan 25, 2000
Method of increasing testosterone
PFIZER26 citations92
US6632834B2Oct 14, 2003
Compositions and methods for treating conditions responsive to estrogen
PFIZER42 citations91
US6403611B2Jun 11, 2002
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER13 citations82
US6274618B1Aug 14, 2001
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
PFIZER14 citations82
US5861438AJan 19, 1999
Combination therapy to prevent bone loss parathyroid hormone and estrogen agonists
PFIZER14 citations74
US5773477AJun 30, 1998
Combination therapy to treat osteoporosis - polyphosphonates and estrogen agonists
PFIZER13 citations74
US5719191AFeb 17, 1998
1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's disease
PFIZER8 citations74
US5589482ADec 31, 1996
Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
PFIZER15 citations74
US7255984B2Aug 14, 2007
Combination therapy for osteoporosis
PFIZER9 citations73
US6492412B2Dec 10, 2002
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER9 citations73
US6426359B1Jul 30, 2002
Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists
PFIZER12 citations73
US6642266B2Nov 4, 2003
EP4 receptor selective agonists in the treatment of osteoporosis
PFIZER7 citations72
US6132774AOct 17, 2000
Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
PFIZER12 citations72
US6100301AAug 8, 2000
Combination therapy to treat osteoporosis-polyphosphonates and estrogen agonists
PFIZER3 citations63
US5726207AMar 10, 1998
Protection of ischemic myocardium against reperfusion damage
PFIZER5 citations63
US5719190AFeb 17, 1998
Inhibition of myeloperoxidase activity
PFIZER5 citations63
US6998423B2Feb 14, 2006
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER2 citations62
US6737437B2May 18, 2004
EP4 receptor selective agonists in the treatment of osteoporosis
PFIZER4 citations61
US6620806B2Sep 16, 2003
Methods and kits for improving vascular health
PFIZER5 citations61
US5902830AMay 11, 1999
Use of droloxifene for the treatment of cardiovascular disease
PFIZER2 citations61
US6057309AMay 2, 2000
Combination therapy to prevent bone loss-progesterone and estrogen agonists
PFIZER0 citations52
US5985932ANov 16, 1999
Inhibition of autoimmune diseases
PFIZER0 citations52
US5733937AMar 31, 1998
Methods for alleviating symptoms of premenstrual syndrome and late luteal phase dysphoric disorder
PFIZER1 citations52
US6284773B1Sep 4, 2001
Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin E2
PFIZER1 citations51
ATLANTIC RICHFIELD CO
5 patentsUS5933789AAug 3, 1999
Method and system for applying dispersive normal moveout corrections to seismic survey signals
ATLANTIC RICHFIELD CO63 citations94
US5764516AJun 9, 1998
Method and system for surface-consistent phase and time lag correction of seismic data
ATLANTIC RICHFIELD CO47 citations92
US5079703AJan 7, 1992
3-dimensional migration of irregular grids of 2-dimensional seismic data
ATLANTIC RICHFIELD CO33 citations92
US5051961ASep 24, 1991
Method and apparatus for seismic survey including using vertical gradient estimation to separate downgoing seismic wavefield
ATLANTIC RICHFIELD CO43 citations89
US5154254AOct 13, 1992
Mass retrieval for acoustic pulse generator
ATLANTIC RICHFIELD CO16 citations71